These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 750157)

  • 1. Effect of saralasin and serum in myohaemoglobinuric acute renal failure of rats.
    Bauereiss K; Hofbauer KG; Konrads A; Gross F
    Clin Sci Mol Med; 1978 May; 54(5):555-60. PubMed ID: 750157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system in acute renal failure of rats.
    Rauh W; Oster P; Dietz R; Gross F
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):467-73. PubMed ID: 1056277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of angiotensin II inhibition on acute renal failure after intravascular coagulation in the rat.
    Ståhl E; Gerdin B; Rammer L
    Nephron; 1981; 29(5-6):250-7. PubMed ID: 7033809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and renin in glycerol-induced acute renal failure in the rat.
    Hofbauer KG; Konrads A; Bauereiss K; Möhring B; Möhring J; Gross F
    Circ Res; 1977 Oct; 41(4):424-8. PubMed ID: 902352
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of 1-sarcosine, 8-leucyl angiotensin II on glycerol-induced acute renal failure.
    Baranowski RL; O'Connor GH; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):322-31. PubMed ID: 1190925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High renin activity accompanying angiotensin II inhibition in rats with ischemic renal failure.
    Shapira J; Iaina A; Eliahou HE; Solomon S
    Isr J Med Sci; 1976 Feb; 12(2):124-8. PubMed ID: 1262200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial studies of the renin system in rats with glycerol-induced renal failure.
    Carvalho JS; Page LB
    Nephron; 1978; 20(1):47-53. PubMed ID: 619300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of an angiotensin II antagonist to influence isoprenaline-induced antidiuresis in rats.
    Greven J; Pantel J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):271-5. PubMed ID: 3713872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma renin substrate, plasma and renal renin, and plasma osmolarity during glycerol-induced acute renal failure in rabbits.
    Torres VE; Strong CG; Romero JC; Wilson DM
    Mayo Clin Proc; 1975 Mar; 50(3):111-20. PubMed ID: 1117758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an angiotensin blocker (saralasin) on kidney function in dehydrated sheep.
    Yesberg NE; Henderson M; Wilson K; Law S; Cross RB
    Q J Exp Physiol; 1982 Jan; 67(1):97-103. PubMed ID: 7079453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of an angiotensin II antagonist (saralasin) as an adjunct during renal vein catheterization.
    Ibsen H; Giese J; Rabøl A; Kappelgaard AM
    Scand J Clin Lab Invest; 1980 Apr; 40(2):115-20. PubMed ID: 7020064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.